Clinical Trial Update: Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the safety and efficacy of Ingenol Mebutate 0.05% gel after cryotherapy in hypertrophic actinic keratoses; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Picato (ingenol mebutate) 0.05% gel (ingenol mebutate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Actinic Keratoses | Phase 4 | Status: COMPLETED | Results posted: 2017-04-26